Pelisch and colleagues investigated the molecular mechanisms by which stromelysin-1/matrix metalloproteinase-3 (MMP3), a stromal enzyme upregulated in many breast tumors and other stroma-rich cancers, leads to induction of RAC1B expression. This evidence concerns the gene MMP3 and breast neoplasm.